Introduction
Dopamine (DA) signaling in the striatum plays a central role in a variety of motor and cognitive activities. Abnormal striatal DAergic transmission is involved in several neuropsychiatric diseases, such as parkinsonism, schizophrenia, and drug addiction (Berke and Hyman, 2000; Lewis and Lieberman, 2000; Obeso et al., 2000) . Endogenous DA, released from midbrain DA neurons, modulates striatal function by interacting with DA receptors. Among the various subtypes of DA receptors, the D 1 -like family has been involved in the regulation of motor activity and in the expression of activity-dependent synaptic plasticity at corticostriatal synapses. Accordingly, pharmacological inhibition of D 1 -like receptors reduces spontaneous motor activity (Meyer et al., 1993; Vallone et al., 2000) and prevents both long-term depression (LTD) and long-term potentiation (LTP) (Calabresi et al., 1992a (Calabresi et al., , 2000 Centonze et al., 2001; Kerr and Wickens, 2001 ). To date, however, it is still unknown which member of the D 1 -like family of DA receptors (D 1 or D 5 ) mediates these actions of DA in the striatum. In this respect, both D 1 and D 5 receptors are expressed in the striatum (Bergson et al., 1995; Surmeier et al., 1996; Yan and Surmeier, 1997; Rivera et al., 2002a) , are positive regulators of adenylyl cyclase activity (Stoof and Kebabian, 1981; Grandy et al., 1991; Sunahara et al., 1991; Tiberi et al., 1991; Vallone et al., 2000) , and might be, in principle, equally important for both motor activity and ordered synaptic plasticity. However, the evidence that the quantitative ratios of these receptors differ significantly in the various neuronal populations of the striatum (Bergson et al., 1995; Surmeier et al., 1996; Yan and Surmeier, 1997; Rivera et al., 2002a) supports the concept that they serve distinct physiological roles.
In the present study, therefore, we used mice in which the expression of DA D 1 receptors was selectively disrupted to analyze the involvement of D 1 and D 5 receptors in locomotor activity and corticostriatal LTD and LTP.
Materials and Methods
Male wild-type (WT) and D 1 DA receptor knock-out (D 1 Ϫ/Ϫ) mice (Xu et al., 1994 ) (2-3 months of age) were used for all the experiments.
Locomotor activity. For locomotor activity studies, we used a multicage activity meter system (Digiscam Animal Activity Monitor; Columbus Instruments, Columbus, OH). This apparatus consisted of eight individual mice cages (21 ϫ 21 ϫ 30 cm), equipped with two sets (one above the other) of eight photocell beams per side spaced 2.5 cm to measure horizontal and vertical activity. WT and D 1 Ϫ/Ϫ mice were habituated to the cages for 3 consecutive days, and basal activity was recorded for 3 hr on the following day. The motor-suppressing effect of SCH 23390 (a D 1 /D 5 receptor antagonist) at the doses of 30, 50, 100, and 300 g/kg was tested in both mouse genotypes in 3 hr sessions. Each group was composed of eight animals, and each animal was used as its own control. All injections were administered intraperitoneally, in 1 ml/100 gm body weight/volume, and SCH 23390 (Tocris Cookson, Bristol, UK) was dissolved in saline.
Electrophysiology. Intracellular and whole-cell patch-clamp electrophysiological recordings were performed in vitro from brain slices. The preparation and maintenance of coronal corticostriatal slices have been described previously (Calabresi et al., 1997 (Calabresi et al., , 2000 Centonze et al., 2002b) . Briefly, coronal slices (200 -300 m) were prepared from tissue blocks by use of a vibratome. The slices included the neostriatum and the neocortex. A single slice was transferred to a recording chamber and submerged in a continuously flowing Krebs' solution (32-33°C, 2-3 ml/min) gassed with a 95% O 2 and 5% CO 2 mixture. The composition of the solution was as follows (in mM): 126 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 1.2 MgCl 2 , 2.4 CaCl 2 , 11 glucose, and 25 NaHCO 3 .
For intracellular recordings, sharp electrodes were used. They were filled with 2 M KCl (30 -60 M⍀). An Axoclamp 2A amplifier (Axon Instruments, Foster City, CA) was used for recordings in either currentclamp or voltage-clamp mode. For synaptic stimulation, bipolar electrodes were used. The stimulating electrode was located in either the cortical areas close to the recording electrode or the white matter between the cortex and the striatum. As the conditioning high-frequency stimulation (HFS), we used three trains (3 sec duration, 100 Hz frequency, at 20 sec intervals).
An Axopatch 1D amplifier (Axon Instruments) was used for wholecell patch-clamp recordings. Currents steps were generated using pClamp version 8.0 software (Axon Instruments). The striatum could be readily identified under low-power magnification, whereas individual neurons were visualized in situ using a differential interference contrast (Nomarski) optical system. This used an Olympus Optical (Tokyo, Japan) BX50WI non-inverted microscope with 40ϫ water immersion objective combined with an infrared filter, a monochrome CCD camera (model 4912; Cohu, San Diego, CA), and a personal computercompatible system for analysis of images and contrast enhancement (WinVision 2000; Delta Sistemi, Rome, Italy). Recordings were made with borosilicate glass pipettes (1.8 mm outer diameter; 3-5 M⍀) containing the following (mM): 125 K ϩ -gluconate, 10 NaCl, 1.0 CaCl 2 , 2.0 MgCl 2 , 1 BAPTA, 19 HEPES, 0.3 guanosine triphosphate, and 2.0 Mgadenosine triphosphate, adjusted to pH 7.3 with KOH.
Quantitative data on post-tetanic or post-treatment modifications are expressed as percentage of the controls, the latter representing the mean of responses recorded during a stable period (15-30 min) before tetanic stimulation or drug application. Each data point in the graphs in the figures was obtained from at least five single neurons. Student's t test and 2 test (for paired and unpaired observations) were used to compare the means, and ANOVA was used when multiple comparisons were made against a single control group.
Drugs were applied by dissolving them to the desired final concentration in saline and by switching the perfusion from control saline to drugcontaining saline. The drugs used were as follows: APV, CNQX, SCH 23390, S-nitroso-N-acetylpenicillamine (SNAP), 7-nitroindazole monosodium salt (7-NINA) (Tocris Cookson), DA, nifedipine, quinpirole, SKF 38393 (Sigma-RBI, St. Louis, MO), H89 (Calbiochem, La Jolla, CA), and zaprinast (Rhône-Poulenc Rorer, Dagenham, UK).
Immunocytochemistry. For immunocytochemical studies, WT (n ϭ 4) and D 1 Ϫ/Ϫ mice (n ϭ 5) were deeply anesthetized with sodium pentobarbital and perfused transcardially with 4% paraformaldehyde made in 0.1 M phosphate buffer, pH 7.4. Brains were removed, postfixed in the same solution for 2 hr at 4°C, cryoprotected with 30% sucrose in 0.1 M PBS, frozen in dry ice, and sectioned (25 m thick) in a freezing microtome. Coronal sections through the striatum were collected and stored in PBS with 0.02% sodium azide at 4°C for immunocytochemistry. All studies were approved by the appropriate animal care committee.
To localize D 5 DA receptors, a polyclonal rabbit antibody against the D 5 receptor subtype (1:2000 dilution) was developed and characterized at the Cajal Institute (Rivera et al., 2002a; Centonze et al., 2003) . Somatostatin (SS) interneurons in the striatum correspond to neurons that express nitric oxide synthase (NOS) (Vincent et al., 1983) . Therefore, to localize NOS-positive neurons, we used a monoclonal rat antiserum against somatostatin (1:100 dilution; provided by Drs. J. Rodrigo and A. C. Cuello, Cajal Institute, Consejo Superior de Investigaciones Científicas, Madrid, Spain) (Milstein and Cuello, 1983) . Primary antibodies were diluted in 0.1 M PBS, with 0.2% Triton X-100 (PBS-TX), 1% bovine serum albumin (BSA), and 0.1% sodium azide.
Free-floating double-labeling immunocytochemistry was performed in sections from WT and D 1 Ϫ/Ϫ mice (Rivera et al., 2002a,b) . Briefly, nonspecific binding sites in the sections were blocked with 5% BSA in PBS-TX for 30 min. Sections were washed and incubated with our rabbit polyclonal anti-D 5 antiserum and with the monoclonal anti-SS antibody for 48 hr at 4°C. Sections were then incubated with two secondary antibodies, Alexa 598-conjugated goat anti-rabbit (red; Molecular Probes, Eugene, OR) and with goat anti-rat CY2 (green; Amersham Biosciences, Buckinghamshire, UK) diluted 1:500 in PBS-TX for 1 hr in the dark. In each experiment, the specificity of staining was monitored by incubating control sections with one primary antibody and then with both secondary antibodies to detect any cross-reaction between them. Sections were mounted in PBS/glycerol (1:1) and 2% 1,4-diazabicyclo-[2.2.2]octane (Sigma-Aldrich Química SA, Madrid, Spain), coverslipped, and observed by laser confocal microscopy (TCS-NT; Leica, Wetzlar, Germany).
Results

Effects of D 1 -like receptor blockade on locomotor activity of WT and D 1 ؊/؊ mice
In the absence of any pharmacological challenge, D 1 Ϫ/Ϫ mice were significantly more active than their WT counterparts when tested for locomotor activity. According to a previous report (Xu et al., 1994) , D 1 Ϫ/Ϫ mice interrupted photocell beams more frequently than control mice throughout the whole period of observation ( Fig. 1 A) .
To extend our investigation to the potential role of D 5 receptors on motor activity, we also analyzed the motor effects of SCH 23390, a D 1 /D 5 receptor antagonist, in both WT and D 1 Ϫ/Ϫ mice. In WT mice, administration of SCH 23390 strongly suppressed motor activity, as indicated by a dose-dependent reduction of photocell beam interruptions. The percentage of reduction after 60 min of treatment was ϳ30% with the lowest dose used (30 g/kg) and ϳ80% with the highest dose (300 g/kg). Although the pharmacological effect of SCH 23390 in D 1 Ϫ/Ϫ mice was less pronounced, also in this genotype SCH 23390 induced a reduction of locomotor activity (35 and 45% for 100 and 300 g/kg, respectively), suggesting a facilitatory action of D 5 receptors on motor activity (Fig. 1 B) .
LTD and LTP in WT and D 1 ؊/؊ mice Intracellular recordings from electrophysiologically identified striatal spiny neurons (Calabresi et al., 1992a (Calabresi et al., , 1997 (Calabresi et al., , 2000 Centonze et al., 1999; Kerr and Wickens, 2001) were performed from WT and D 1 Ϫ/Ϫ slices during the activation of corticostriatal terminals. HFS of these terminals was able to produce long-term changes (LTD or LTP) in EPSP amplitude of control mice. As reported previously (Calabresi et al., 1997 (Calabresi et al., , 2000 , HFS protocol was delivered in the presence of 1.2 mM external magnesium to optimize the appearance of LTD, whereas LTP induction was favored by the removal of this ion from the bathing solution. Both forms of synaptic plasticity were present in WT mice (n ϭ 9 for LTD; n ϭ 10 for LTP). Conversely, whereas corticostriatal LTD was still present in slices prepared from D 1 Ϫ/Ϫ mice (n ϭ 11; p Ͻ 0.001), LTP was absent in these mutants (n ϭ 13; p Ͼ 0.05) (Fig. 2) . These data indicate that D 1 receptors are critically important for LTP induction but are unnecessary for LTD. LTD induction, in fact, rather required D 5 receptor stimulation, because this form of synaptic plasticity was blocked in D 1 Ϫ/Ϫ mice (n ϭ 6), as well as in their WT counterparts (n ϭ 6), by preincubation (7-10 min) with the D 1 and D 5 receptor antagonist SCH 23390 (10 M). As reported previously (Calabresi et al., 2000) , SCH 23390 was also able to fully prevent corticostriatal LTP in WT mice (n ϭ 5) (Fig. 3 A, B) .
The number of striatal neurons expressing the NMDAR1 subunit of NMDA receptors is decreased in D 1 Ϫ/Ϫ mice (Ariano et al., 1998) , and the stimulation of D 1 receptors has been found to potentiate NMDA receptor responsiveness in these cells (Cepeda et al., 1998) . These findings might well account for the loss of NMDA receptor-dependent LTP seen in D 1 Ϫ/Ϫ mice. Thus, to address this issue, we measured the amplitude, half-decay time, and duration of the membrane depolarizations induced by HFS in WT and D 1 Ϫ/Ϫ mice during the induction protocol of corticostriatal LTP. These parameters did not significantly differ in the two classes of animals. The amplitude was 42 Ϯ 6 mV in WT (n ϭ 10) and 40 Ϯ 5 mV in D 1 Ϫ/Ϫ mice (n ϭ 13; p Ͼ 0.05). The half-decay time was 3.0 Ϯ 0.4 sec in WT (n ϭ 10) and 3.0 Ϯ 0.6 sec in mutants (n ϭ 13; p Ͼ 0.05). The duration was 8.1 Ϯ 2 sec in WT (n ϭ 10) and 8.2 Ϯ 3 sec in mutants (n ϭ 13; p Ͼ 0.05) (data not shown). In an additional set of experiments, we investigated the effects of the L-type calcium channel blocker nifedipine (10 M, 10 min; n ϭ 5) on the expression of LTP in WT mice. Although this agent has been reported to inhibit the D 1 receptormediated potentiation of NMDA currents (Cepeda et al., 1998) , it failed to prevent corticostriatal LTP ( p Ͻ 0.01) (data not shown).
Effects of protein kinase A inhibition in corticostriatal LTP
and LTD of WT and D 1 ؊/؊ mice Activation of both D 1 and D 5 receptors results in the stimulation of protein kinase A (PKA) activity. Therefore, we tested the effects of the selective PKA inhibitor H89 on both corticostriatal LTD and LTP. In WT mice, the intracellular injection of H89 (100 M) fully blocked LTP (n ϭ 6; p Ͼ 0.05) but failed to prevent HFSinduced LTD in both WT mice (n ϭ 5; p Ͻ 0.01) and D 1 Ϫ/Ϫ animals (n ϭ 5; p Ͻ 0.01). In contrast, when H89 (10 M; n ϭ 4 for each experimental condition) was added to the perfusing solution, LTP of WT mice and LTD of both WT and D 1 Ϫ/Ϫ mice were prevented ( p Ͼ 0.05 for both conditions) (Fig. 3C,D) . These findings confirm the requirement of PKA stimulation for corticostriatal LTP and LTD in both WT and D 1 Ϫ/Ϫ mice and indicate that LTP induction required the stimulation of the D 1 -PKA pathway in the projection neuron, whereas LTD depended on the activation of D 5 -PKA signaling in a neuronal subtype other than the recorded spiny neuron.
Expression of D 5 receptors in NOS-positive striatal neurons
The SS-and NOS-positive interneuron is a major candidate for the action of DA during the induction phase of corticostriatal LTD. Physiological studies, in fact, have suggested that intrastriatal release of nitric oxide (NO) is a critical factor for LTD induction, by promoting through a feedforward mechanism the stimulation of the cGMP-PKG pathway in spiny projection neurons . In line with this idea, DA D 1 -like receptor stimulation depolarizes putative NO-producing interneurons (Centonze et al., 2002a) and increases striatal levels of cGMP (Altar et al., 1990; Morris et al., 1997) . The inability of D 1 receptor disruption in preventing LTD, therefore, might depend on a normal sensitivity to DA of D 1 Ϫ/Ϫ SS-positive interneurons.
To address this issue, we performed double-labeling immunofluorescence experiments in both WT and D 1 Ϫ/Ϫ mice to investigate whether SS-positive interneurons (which correspond to NOS-positive neurons) (Vincent et al., 1983) of the striatum expressed D 5 receptors. Although a small population of SSpositive neurons lacked D 5 receptors (Fig. 4 B, C, asterisks) , the large majority of both WT and D 1 Ϫ/Ϫ SS-positive cells expressed D 5 receptors (Fig. 4C,F, arrowheads) . These receptors were also present in other medium-and large-sized neurons on the striatum, as shown previously (Rivera et al., 2002a) .
Effects of DA receptor stimulation in low-threshold spike interneurons of D 1 ؊/؊ mice SS-and NOS-positive interneurons correspond to the electrophysiologically identified low-threshold spike (LTS) cells (Kawaguchi, 1993; Kawaguchi et al., 1995) . Thus, we recorded from these neurons in striatal slices of D 1 Ϫ/Ϫ mice. The electrophysiological features of LTS interneurons of D 1 Ϫ/Ϫ mice were unique among striatal cells and consisted essentially in low resting membrane potential (Ϫ58 Ϯ 2 mV), exceptionally high input resistance (520 Ϯ 166 M⍀, measured with patch-clamp electrodes), and in the ability to generate, in addition to fast spikes, large plateau depolarizations and low-threshold calcium spikes during depolarizing current pulses and immediately after hyperpolarization (Fig. 5A ). These features did not significantly differ from those reported previously (Kawaguchi, 1993; Koos and Tepper, 1999; Centonze et al., 2002a) .
In all tested D 1 Ϫ/Ϫ LTS cells (three of three), application of 30 M DA (4 -8 min) elicited a slow and reversible membrane depolarization, which was sufficient to initiate a train of action potentials. This excitatory effect was likely mediated by D 5 receptors, because it was mimicked by the D 1 -like receptor agonist SKF 38393 (10 M; n ϭ 3; p Ͻ 0.01) but not by the D 2 -like receptor agonist quinpirole (10 M; n ϭ 3; p Ͼ 0.01) and was blocked by 10 M SCH 23390 (Fig. 5B) .
Role of the NO-cGMP pathway in corticostriatal LTD recorded from D 1 ؊/؊ mice The idea that the integrity of striatal LTD in D 1 Ϫ/Ϫ mice depends on an intact response to DA of NO-producing interneurons predicts that, also in D 1 Ϫ/Ϫ mice, striatal LTD requires NO-cGMP pathway stimulation downstream D 5 receptors. In D 1 Ϫ/Ϫ mice, therefore, we studied the effect of the NO donor SNAP (100 M) and the selective cGMP phosphodiesterase inhibitor zaprinast (15 M) on corticostriatal EPSP amplitude recorded in the presence of 10 M SCH 23390. As shown in Figure  5C , incubation (7 min) with SNAP (n ϭ 4) or zaprinast (n ϭ 6) induced corticostriatal LTD in D 1 Ϫ/Ϫ slices bathed with SCH 23390 ( p Ͻ 0.01 for both experimental conditions). In addition, as reported in control animals , also in D 1 Ϫ/Ϫ mice HFS-induced LTD was fully prevented by the NOS inhibitor 7-NINA (10 M; n ϭ 5; p Ͼ 0.05) (Fig. 5D) .
Discussion
In the present study, we provided evidence that the two members of D 1 -like family of DA receptors exert distinct roles in motor activity and corticostriatal synaptic plasticity. In particular, whereas genetic ablation of D 1 receptors blocked LTP induction and increased locomotor activity, pharmacological blockade of D 1 /D 5 receptors by SCH 23390 prevented LTD and inhibited motor activity in both WT and D 1 Ϫ/Ϫ mice.
Complex regulation of locomotor activity by D 1 and D 5 receptors
In D 1 Ϫ/Ϫ mice, locomotion was increased, whereas SCH 23390, a D 1 and D 5 receptor blocker, caused in the two groups of animals suppression of motor activity. SCH 23390, however, was less effective and less potent in D 1 -lacking animals than in control mice in inhibiting motor activity, suggesting that D 1 receptors also exert a permissive action on D 5 receptor function. To explain the dual role of D 1 receptors in motor control, it can be speculated that D 1 receptors synergize with D 5 receptors when the two receptors are activated in the same cellular subtype, but they oppose to each other when activated in distinct neuronal populations. This hypothesis is supported by the following data. First, both D 1 and D 5 receptors are positive regulators of cAMP levels (Grandy Sunahara et al., 1991; Tiberi et al., 1991; Vallone et al., 2000) and therefore cooperate in triggering common cellular events when coexpressed. In this respect, D 5 receptors are also expressed in medium spiny neurons of the striatum (Rivera et al., 2002a ; present study), a neuronal subtype particularly enriched in D 1 receptors (Gerfen et al., 1990; Le Moine et al., 1991; Surmeier et al., 1992 Surmeier et al., , 1996 Aizman et al., 2000) . Second, D 1 and D 5 receptors are primarily expressed in different striatal cell populations (Bergson et al., 1995; Surmeier et al., 1996; Yan and Surmeier, 1997; Rivera et al., 2002a) , suggesting that they can also exert distinct physiological actions. Noticeably, NOS-positive neurons, which express D 5 receptors and are stimulated by D 1 -like receptor agonists, do not have D 1 receptors (Le Moine et al., 1991; Kawaguchi et al., 1995; Rivera et al., 2002a) and cause longterm inhibition of the excitability of striatal spiny neurons, thereby contrasting the direct LTP-favoring effects of D 1 receptors on these cells. In this line, DAergic activation of NOSpositive cells causes a long-term inhibition of medium spiny neurons detected by a reduction of c-Fos expression in striatal matrix neurons (Moratalla et al., 1996a,b) .
Other interpretations of our results are also possible. Accordingly, the postulated inhibitory role of D 1 receptors only emerges from the increased motor activity seen in D 1 Ϫ/Ϫ mice, although it could in principle result from a variety of developmental or compensatory changes. In addition, the evidence that the D 1 /D 5 receptor antagonist SCH 23390 inhibited locomotor activity in both WT and D 1 Ϫ/Ϫ and that this action was more pronounced in WT might also suggest that D 1 receptors exert only stimulatory actions on locomotor activity by synergizing with D 5 receptors. The use of the recently generated mice lacking D 5 receptors (Holmes et al., 2001; Hollon et al., 2002) could help to clarify this important issue.
Complex regulatory role of DA receptors in corticostriatal synaptic plasticity Repetitive stimulation of corticostriatal pathway can induce either LTD or LTP both in vivo (Charpier and Deniau, 1997; Reynolds and Wickens, 2000) and in vitro (Calabresi et al., 1992a,b; Dos Santos Villar and Walsh, 1999; Partridge et al., 2000) . Persistent changes in synaptic strength in the striatum are considered as neural correlates of specific motor abilities, although more recently have been involved in several other aspects of brain activity, such as reward-related learning (Berke and Hyman, 2000; Reynolds et al., 2001) , maturation of neural circuitry during development (Choi and Lovinger, 1997) , and drug addiction (Berke and Hyman, 2000; Hyman and Malenka, 2001; Nestler, 2001) .
A solid achievement in the field of basal ganglia physiology is the requirement of DA for corticostriatal synaptic plasticity. The unavailability of pharmacological agents able to target selectively specific members of the two subfamilies of DA receptors, however, makes essential the use of mutant mice to identify the receptor subtypes involved in these physiological activities. On the basis of this consideration, mice lacking DA D 2 receptors have been used previously for electrophysiological experiments in vitro. These experiments allowed to identify the D 2 receptor as the specific member of the D 2 -like subfamily involved in the facilitatory effect on LTD and in the restraining action on LTP (Calabresi et al., 1997) . Together, these results with the present data and with the observations that both D 1 -and D 2 -like antagonists block locomotor activity (Vallone et al., 2000) and striatal LTD (Calabresi et al., 1992a,c) , it is possible to conclude that D 5 and D 2 receptors cooperate functionally to facilitate motor activity and striatal LTD, whereas D 1 and D 2 receptors are the receptor subtypes mainly involved in striatal LTP and, possibly, motor inhibition. It is also possible, however, that the role of D 5 receptors in LTD only emerges as a compensatory mechanism after D 1 receptor ablation and that it is negligible in control conditions. Again, the use of D 5 receptor-lacking mice will prove useful to clarify this issue.
Concluding remarks
Current models of the basal ganglia organization propose that the striatum is an important component of motor, cognitive, and limbic circuits. This nucleus takes part in several brain activities by processing the flow of information arising from different neocortical areas and projecting to the thalamus (Bergman et al., 1998) . DA plays a crucial role in these processes by affecting the activity of striatal cells through multiple mechanisms. Interestingly, a complex interplay between different subtypes of DA receptors is required for both striatal motor control and synaptic plasticity, possibly involving different subpopulations of striatal neurons.
Investigating the receptor and cellular mechanisms involved in striatal motor control and synaptic plasticity is an essential requirement to understand the neural bases of critical brain functions and of dramatic pathological conditions, such as Parkinson's disease, schizophrenia, and drug addiction. 
